Bio-Techne Corporation
IT ˙ BIT ˙ US09073M1045
54,00 € 0,00 (0,00%)
2026-06-03
AKTIENPREIS
SecurityIT:1TECH / Bio-Techne Corporation
InstitutionEmpirical Finance, LLC
Latest Disclosed Ownership4,289 shares
Latest Disclosed Value $ 224,143
Empirical Finance, LLC reports 0.21% decrease in ownership of 1TECH / Bio-Techne Corporation

On May 14, 2026 - Empirical Finance, LLC filed a 13F-HR/A form disclosing ownership of 4,289 shares of Bio-Techne Corporation (IT:1TECH) valued at $231,606 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 4,298 shares of Bio-Techne Corporation. This represents a change in shares of -0.21% during the quarter. The current value of the position is $231,606 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F/A-1 BIO-TECHNE COM 09073M104 4,289 -9 -0.21 224 -11.11 0.0105
2026-05-14 2026-03-31 13F BIO-TECHNE COM 09073M104 4,289 -9 224 0.0105
2026-02-12 2025-12-31 13F BIO-TECHNE COM 09073M104 4,298 -195 -4.34 253 1.20 0.0121
2025-11-13 2025-09-30 13F BIO-TECHNE COM 09073M104 4,493 54 1.22 250 9.21 0.0119
2025-08-11 2025-06-30 13F BIO-TECHNE COM 09073M104 4,439 40 0.91 228 -11.28 0.0120
2025-05-07 2025-03-31 13F BIO-TECHNE COM 09073M104 4,399 314 7.69 258 -12.59 0.0156
2025-01-28 2024-12-31 13F BIO-TECHNE COM 09073M104 4,085 5 0.12 294 -9.82 0.0170
2024-11-06 2024-09-30 13F BIO-TECHNE COM 09073M104 4,080 160 4.08 326 16.43 0.0190
2024-07-30 2024-06-30 13F BIO-TECHNE COM 09073M104 3,920 -37 -0.94 281 0.72 0.0175
2024-05-06 2024-03-31 13F BIO-TECHNE COM 09073M104 3,957 195 5.18 279 -4.14 0.0171
2024-02-14 2023-12-31 13F BIO-TECHNE COM 09073M104 3,762 91 2.48 290 16.47 0.0202
2023-11-02 2023-09-30 13F BIO-TECHNE COM 09073M104 3,671 605 19.73 250 -0.40 0.0184
2023-07-27 2023-06-30 13F BIO-TECHNE COM 09073M104 3,066 3,066 250 0.0194
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.